• Brand Equity Protection
Join Resolver at Pharmacovigiliance World
With more channels, more signals, and more AI, pharmacovigilance leaders face a complex moment in adverse event detection. Resolver will be at Pharmacovigilance World 2026, ready to discuss solutions for that tension between scaling visibility and engagement online, and meeting rising regulatory expectations from the EMA and FDA.
Visit our booth to find out why leading pharma teams trust Resolver to catch what others miss.
Our team will be on the ground, and our Strategic Client Partner, Emma Durant, will be presenting alongside Caroline Goodwin, Social Enablement & Digital Insights Director from Pfizer on:
- How pharma teams are managing adverse event detection across every channel
- What it looks like to combine AI with PV-trained human expertise at scale
- How global brands are achieving compliance without compromising coverage
Session: More Channels, More Signals, More AI: How Pharma Teams Engage Confidently
Tuesday, 16 June at 09:50 AM
Pre-book a meeting with our team at the event to walk through your current approach to adverse event monitoring.
About Resolver’s Pharmacovigilance Solution
Resolver delivers fully managed adverse event detection that combines AI with PV-trained human verification — purpose-built for global pharmaceutical teams. We provide 100% SLA-backed AE detection, 24/7/365, triple-verified by analysts across 50+ languages, covering owned and paid social media, niche forums, and across the entire web. Built to meet evolving EMA and FDA requirements, we give your team the human check AI can’t replace.
